James Kuo

James Kuo

Founder chez TRYP THERAPEUTICS INC.

Fortune : 146 760 $ au 31/03/2024

58 ans
Health Technology
Finance
Consumer Services

Profil

James S.
Kuo
was the founder of Windtree Therapeutics, Inc. (founded in 1992) and BioMicro Systems, Inc. (founded in 2003), where he held the titles of President & Chief Executive Officer and Chairman & Chief Executive Officer, respectively.
He is also the founder of Tryp Therapeutics, Inc. (founded in 2019) and currently serves as a Director.
Dr. Kuo is also the founder of Monarch Labs, Inc. Dr. Kuo's current jobs include Chairman & Chief Executive Officer at ApoLife, Inc. (since 2012), Chief Executive Officer at Return Health, Inc., Non-Executive Chairman at MSK Pharma LLC, Independent Director at Pharnext SA (starting in 2022), Managing Director at Athena Bioventures, Inc. (since 2007), and Vice President-Research & Development at Silo Pharma, Inc. (starting in 2022).
His former jobs include Chief Executive Officer & IR Contact at FIT Biotech Oy (2016-2018), Chairman & Chief Executive Officer at Cysteine Pharma, Inc. (2006-2007), Chief Executive Officer at OncoTracker, Inc. (2018-2019), Chairman & Chief Executive Officer at KMRB Acquisition Corp.
II, Non-Executive Chairman at Soligenix, Inc. (2004-2009), Chairman at ImmunoPrecise Antibodies Ltd.
(2016-2023), Associate Director-Corporate Licensing at Pfizer Inc. (1995-1997), Managing Director-Venture Analysis at HealthCare Ventures LLC, Director at Cordex Pharma, Inc. (2007-2010), Director at Theriva Biologics, Inc. (2007-2012), and Vice President-Business Development at Myriad Genetics, Inc. (1998-2000).
Dr. Kuo's education includes an undergraduate degree from Haverford College, an MBA from The Wharton School of the University of Pennsylvania, and a doctorate from the University of Pennsylvania Medical Center.
Dr. Kuo is also the founder of Monarch Labs, Inc...

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
09/01/2024 6 000 000 ( 6,22% ) 108 000 $ 31/03/2024
17/03/2023 25 500 ( 0,10% ) 38 760 $ 31/03/2024

Postes actifs de James Kuo

SociétésPosteDébut
TRYP THERAPEUTICS INC. Founder -
PHARNEXT SCA Director/Board Member 16/06/2022
SILO PHARMA, INC. Chief Tech/Sci/R&D Officer 01/09/2022
Chief Executive Officer -
Corporate Officer/Principal 01/01/2007
Chief Executive Officer 27/09/2012
MSK Pharma LLC Chairman 11/04/2011
Founder -
Tous les postes actifs de James Kuo

Anciens postes connus de James Kuo

SociétésPosteFin
IMMUNOPRECISE ANTIBODIES LTD. Chairman 09/11/2023
░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ -
░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de James Kuo

Formation de James Kuo

Haverford College Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin
University of Pennsylvania Medical Center Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de James Kuo

Relations

100 +

Relations au 1er degré

24

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées9
SOLIGENIX, INC.

Health Technology

PFIZER, INC.

Health Technology

WINDTREE THERAPEUTICS, INC.

Health Technology

MYRIAD GENETICS, INC.

Health Technology

SILO PHARMA, INC.

Health Technology

THERIVA BIOLOGICS, INC.

Health Technology

PHARNEXT SCA

Health Technology

IMMUNOPRECISE ANTIBODIES LTD.

Health Technology

TRYP THERAPEUTICS INC.

Health Technology

Entreprise privées12

Health Technology

Finance

Health Technology

Process Industries

Health Technology

Commercial Services

Cysteine Pharma, Inc.

MSK Pharma LLC

Finance

Finance

Health Technology

Health Technology

Voir les connexions sociétés